You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 2, August 1958 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Adaptation of Virac, a New Iodophore, to Clinical Use

JOHN E. HARRIS, M.D.; PETER P. ROWELL, M.D.; OLIVE BEAUDREAU, B.S.

AMA Arch Ophthalmol. 1958;60(2):206-214.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The germicidal properties of iodine are well known. Indeed, it has been used with good results as an antiseptic for many decades. Its merits for this purpose, recently reviewed by Gershenfeld,1 are numerous. First, it is bactericidal rather than bacteriostatic. Second, such action is rapid and is achieved in comparatively low concentration. Third, unlike most germicides, iodine is essentially equipotent against all bacteria. Fourth, in addition to its bactericidal properties, iodine has well-known activity against spores, fungi, and viruses. Fifth, its tissue toxicity is comparatively low, the toxicity index being less than that of benzalkonium chloride, mercuric chloride, or phenol.1

In spite of its potency and widespread use as a home remedy, iodine finds only limited application in clinical medicine. Most commonly iodine has been used as a skin disinfectant prior to surgery. There is little doubt of its value for this purpose.2,3 However, the use of . . . [Full Text PDF of this Article]


Author Affiliations

Portland, Ore.

From the John E. Weeks Memorial Laboratory and Clinics, Department of Ophthalmology, University of Oregon Medical School.


Footnotes

Supported by a grant from Ruson Laboratories, Inc., Portland, Ore.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1958 American Medical Association. All Rights Reserved.